Here are the S-3 shelf registrations from INNOVATE Corp. (VATE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow VATE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VATE filings page.
INNOVATE Corp. (VATE) filed a shelf registration statement amendment to offer, from time to time, up to $100,000,000 of common stock, preferred stock, depositary shares, warrants, subscription rights, purchase contracts and purchase units. Specific terms and prices will be set in future prospectus supplements, and proceeds are expected to be used for general corporate purposes, including financing operations and possible debt repayment.
The company explains it is selling its Infrastructure (DBM Global) and Spectrum (HC2 Broadcasting) segments through the DBMG Sale and Spectrum Merger, transactions that, if completed, would eliminate substantially all consolidated operating revenue and primary subsidiary cash flows. INNOVATE discloses substantial indebtedness, covenant-driven asset sale milestones, required application of DBMG Sale proceeds to repay senior debt and convertible notes, and states there is substantial doubt about its ability to continue as a going concern. It also expects, after these sales, that investment securities may exceed 40% of total assets and that it will rely on a transient investment company exemption under the Investment Company Act while it evaluates future strategic alternatives.
INNOVATE Corp. filed a shelf registration statement allowing it to offer, from time to time, up to $100,000,000 of common stock, preferred stock, depositary shares, warrants, subscription rights, purchase contracts and purchase units. Specific terms and pricing will be detailed in future prospectus supplements.
The company is a diversified holding company with Infrastructure, Life Sciences and Spectrum segments, but has entered into agreements to sell its 91.21% interest in DBM Global (Infrastructure) to IES Holdings and to merge its Spectrum business with CONX Corp. INNOVATE discloses that, if completed, these transactions would eliminate substantially all consolidated operating revenue and primary subsidiary cash flows, leaving mainly minority investments, the Life Sciences segment and limited Other activities.
The risk factors highlight substantial indebtedness, milestone covenants tied to at least $150 million of asset-sale net proceeds for its 10.50% Senior Secured Notes due 2027, substantial doubt about the company’s ability to continue as a going concern, and that common stockholders should not expect to receive proceeds from the DBMG Sale or Spectrum Merger. Following asset sales, INNOVATE expects to qualify as a transient investment company under the Investment Company Act and may face constraints on future investments. Net proceeds from any securities issuance are expected to be used for general corporate purposes, including financing operations and possible debt repayment.